TY - JOUR
T1 - Comparison of Outcomes of Patients with vs without Previous Coronary Artery Bypass Graft Surgery Presenting with ST-Segment Elevation Acute Myocardial Infarction
AU - Karacsonyi, Judit
AU - Schmidt, Christian W.
AU - Okeson, Brynn K.
AU - Garcia, Santiago
AU - Henry, Timothy D.
AU - Nikolakopoulos, Ilias
AU - Vemmou, Evangelia
AU - Xenogiannis, Iosif
AU - Sharkey, Scott
AU - Aguirre, Frank V.
AU - Tannenbaum, Mark
AU - Nicholas Burke, M.
AU - Goessl, Mario
AU - Sorajja, Paul
AU - Traverse, Jay
AU - Wang, Yale L.
AU - Brilakis, Emmanouil S.
N1 - Funding Information:
Funding: Minneapolis Heart Institute Foundation and Abbott Northwestern Hospital.
Funding Information:
Dr. Garcia. Institutional research grants from Edwards Lifesciences, Medtronic, Abbott Vascular, Biotronik and BSCI. Consultant: Neochord, Abbott Vascular, Medtronic and BSCI. Proctor: Edwards Lifesciences. Dr. Burke: speaker for Opsens Medical; has served as a consultant for Abbott Vascular; and owns equity in Egg Medical and MHI Ventures. Dr. Brilakis: consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor Circulation), Amgen, Asahi Intecc, Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), ControlRad, CSI, Elsevier, GE Healthcare, InfraRedx, Medicure, Medtronic, Opsens, Siemens, and Teleflex; owner, Hippocrates LLC; shareholder: MHI Ventures, Cleerly Healths. All other authors: declaration of interest: none.
Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2021/9/1
Y1 - 2021/9/1
N2 - The outcomes of patients with previous coronary bypass graft surgery (CABG) presenting with ST-segment elevation acute myocardial infarction (STEMI) have received limited study. We compared the clinical and procedural characteristics and outcomes of STEMI patients with and without previous CABG in a contemporary multicenter STEMI registry between 2003 and 2020. The primary outcomes of the study were mortality and major cardiac adverse events (MACE: death, MI or stroke). Survival curves were derived using the Kaplan-Meier method and compared with the log-rank test. Of the 13,893 patients included in the analyses, 7.2% had previous CABG. Mean age was 62.4 ± 13.6 years, most patients (71%) were men and 22% had diabetes. Previous CABG patients were older (69.0 ± 11.7 vs 61.9 ± 13.6 years, p <0.001) and more likely to have diabetes (40% vs 21%, p <0.001) compared with patients without previous CABG. Previous CABG patients had higher mortality and MACE at 5 years (p <0.001). Outcomes were similar with saphenous vein graft vs native coronary culprits. Previous CABG remained associated with mortality from discharge to 18 months (p = 0.044) and from 18 months to 5 years (p <0.001) after adjusting for baseline characteristics. Long term outcomes after STEMI were worse among patients with previous CABG compared with patients without previous CABG, even after adjustment for baseline characteristics.
AB - The outcomes of patients with previous coronary bypass graft surgery (CABG) presenting with ST-segment elevation acute myocardial infarction (STEMI) have received limited study. We compared the clinical and procedural characteristics and outcomes of STEMI patients with and without previous CABG in a contemporary multicenter STEMI registry between 2003 and 2020. The primary outcomes of the study were mortality and major cardiac adverse events (MACE: death, MI or stroke). Survival curves were derived using the Kaplan-Meier method and compared with the log-rank test. Of the 13,893 patients included in the analyses, 7.2% had previous CABG. Mean age was 62.4 ± 13.6 years, most patients (71%) were men and 22% had diabetes. Previous CABG patients were older (69.0 ± 11.7 vs 61.9 ± 13.6 years, p <0.001) and more likely to have diabetes (40% vs 21%, p <0.001) compared with patients without previous CABG. Previous CABG patients had higher mortality and MACE at 5 years (p <0.001). Outcomes were similar with saphenous vein graft vs native coronary culprits. Previous CABG remained associated with mortality from discharge to 18 months (p = 0.044) and from 18 months to 5 years (p <0.001) after adjusting for baseline characteristics. Long term outcomes after STEMI were worse among patients with previous CABG compared with patients without previous CABG, even after adjustment for baseline characteristics.
UR - http://www.scopus.com/inward/record.url?scp=85109424314&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109424314&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2021.05.041
DO - 10.1016/j.amjcard.2021.05.041
M3 - Article
C2 - 34243937
AN - SCOPUS:85109424314
SN - 0002-9149
VL - 154
SP - 33
EP - 40
JO - American Journal of Cardiology
JF - American Journal of Cardiology
ER -